J Knee Surg 2022; 35(06): 585-596
DOI: 10.1055/s-0042-1743221
Special Focus Section

Management of Primary Aggressive Tumors of the Knee

John R. Martin
1   Department of Orthopaedic Surgery, University of Arizona College of Medicine, Phoenix, Arizona
,
1   Department of Orthopaedic Surgery, University of Arizona College of Medicine, Phoenix, Arizona
,
Michael D. Duran
2   The Center for Orthopedic Research and Eduction (CORE) Institute, Phoenix, Arizona
,
Amalia M. de Comas
1   Department of Orthopaedic Surgery, University of Arizona College of Medicine, Phoenix, Arizona
2   The Center for Orthopedic Research and Eduction (CORE) Institute, Phoenix, Arizona
,
David J. Jacofsky
2   The Center for Orthopedic Research and Eduction (CORE) Institute, Phoenix, Arizona
› Institutsangaben

Funding None.
Preview

Abstract

Primary bone sarcomas and aggressive benign bone tumors are relatively rare. It is essential to recognize features that are concerning for these aggressive tumors based on a patient's history, physical exam, and radiographs. Physicians and other health care providers should have a high suspicion for these tumors and promptly refer these patients to orthopaedic oncologists. A multidisciplinary, team-based approach is required to obtain an accurate diagnosis and provide comprehensive care. This review discussed the appropriate work-up, biopsy principles, relevant peri-operative medical management, and surgical treatment options for patients with aggressive primary bone tumors around the knee. Primary bone sarcomas (osteosarcoma and chondrosarcoma) and aggressive benign bone tumors (giant cell tumor, chondroblastoma, and chondromyxoid fibroma) that have a predilection to the distal femur and proximal tibia are the focus of this review.



Publikationsverlauf

Eingereicht: 02. Dezember 2021

Angenommen: 22. Dezember 2021

Artikel online veröffentlicht:
18. Februar 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA